PGKCX
Price
$26.03
Change
+$0.14 (+0.54%)
Updated
Jun 25 closing price
Net Assets
38.58M
PRGTX
Price
$22.50
Change
+$0.21 (+0.94%)
Updated
Jun 25 closing price
Net Assets
4.72B
Interact to see
Advertisement

PGKCX vs PRGTX

Header iconPGKCX vs PRGTX Comparison
Open Charts PGKCX vs PRGTXBanner chart's image
PGIM Jennison Technology C
Price$26.03
Change+$0.14 (+0.54%)
VolumeN/A
Net Assets38.58M
T. Rowe Price Global Technology
Price$22.50
Change+$0.21 (+0.94%)
VolumeN/A
Net Assets4.72B
PGKCX vs PRGTX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGKCX vs. PRGTX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGKCX is a Buy and PRGTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRGTX has more cash in the bank: 4.72B vs. PGKCX (38.6M). PGKCX (0.00) and PRGTX (0.00) have matching dividends . PGKCX was incepted earlier than PRGTX: PGKCX (7 years) vs PRGTX (25 years). PGKCX (3.01) is less costly to investors than PRGTX (0.92). PGKCX is a more actively managed with annual turnover of: 55.00 vs. PRGTX (31.40). PGKCX has a lower initial minimum investment than PRGTX: PGKCX (1000) vs PRGTX (2500). PRGTX annual gain was more profitable for investors over the last year : 13.20 vs. PGKCX (3.85). PGKCX return over 5 years is better than : 77.57 vs. PRGTX (11.01).
PGKCXPRGTXPGKCX / PRGTX
Total Expense Ratio1.850.92201%
Annual Report Gross Expense Ratio3.010.92327%
Fund Existence7 years25 years-
Gain YTD2.4536.85536%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets38.6M4.72B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year3.8513.2029%
Returns for 3 years104.3473.46142%
Returns for 5 years77.5711.01705%
Returns for 10 yearsN/A64.62-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSQRX31.49N/A
N/A
Goldman Sachs Small Cap Value R
GKIRX26.58N/A
N/A
Goldman Sachs Income Builder Inv
AHSZX19.31N/A
N/A
Alger Health Sciences Z
BRULX16.06N/A
N/A
MFS Blended Research Value Equity R3
TRZLX42.85N/A
N/A
T. Rowe Price US Large-Cap Core Z